NCT06109415View on ClinicalTrials.gov

A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

July 18, 2022

Study Completion Date

July 29, 2022

Conditions
Postoperative PainTotal Shoulder ArthroplastyMultimodal Analgesia
Interventions
DRUG

HTX-011

400 mg

DRUG

Bupivacaine Hydrochloride

100 mg

DRUG

Ibuprofen

400 mg

DRUG

Acetaminophen

1 g

DEVICE

Luer lock applicator

Applicator for instillation

Trial Locations (5)

72211

Woodland International Research Group, LLC, Little Rock

74037

Center for Orthopaedic Reconstruction and Excellence, Jenks

75006

Legent Orthopedic Hospital, Carrollton

77401

First Surgical Hospital, Bellaire

84107

JBR Clinical Research, Salt Lake City

Sponsors

Lead Sponsor

Heron Therapeutics
All Listed Sponsors
lead

Heron Therapeutics

INDUSTRY